Alterar idioma para EnglishAlterar idioma para Japonês

Brazil: Pharmacovigilance Risk in Evolving Biosimilar Regulation

3月 01, 2015
flag
特許
This content is available on the FDLI

‍

Rob Rodrigues, attorney at law, had his article “Brazil: Pharmacovigilance Risk in Evolving Biosimilar Regulation” published on the FDLI – Food and Drug Law Institute website. Read it in full at: http://static.lickslegal.com/pdf/FDLI%20-%20Brazil_Pharmacovigilance_Risk_in_Evolvin%202015.pdf

‍

Carregando navegação...

RECENT PUBLICATIONS

LINKEDIN FEED

ícone